DOI: 10.36347/sjams.2020.v08i05.017

Pages: 1253-1258

Objective: In this study our main goal is to describe the effectiveness of misoprostol in medical management of incomplete abortion. Method: This Quasi experimental study was done on 100 patients with incomplete abortion cases who fulfilled the inclusion and exclusion criteria were enrolled for the study at Dhaka medical college and hospital from August 2011 to January 2012. Result: During the result according to parity 32(32.0%) patients was found primi gravida; 32(32.0%) second gravida; 18(18.0%) third gravida, 12(12.0%) fourth gravida, 4(4.0%) fifth gravida and 2(2.0%) was sixth gravida. Among primi gravida 4(4.0%) patients required 1st dose, 10(10.0%) 2nd doses, 6(6.0%) 3rd doses and 12(12.0%) in 4th doses. Among multi gravida 22(22.0%) patients required 1st dose, 20(20.0%) 2nd doses, 10(10.0%) 3rd doses and 12(12.0%) in 4th doses. 65% patients strongly agreed about easy ingestion of the drug 33(33.3%) agreed and disagree 2(2.0%), 5% of patients strongly agreed of having discomfort after ingestion of the drug, 15% disagreed, 30% uncertain. Conclusion: This study concluded that misoprostol is the potential and effective drug in the medical management of incomplete abortion. Treatment with misoprostol can reduce the demand for surgical evacuation in cases of incomplete abortion. Further study is needed for better outcome.